Anonymous
Guest
Anonymous
Guest
The end of the bio-onc winning streak is here. MetMab is dead and so is half of the lung franchise. Layoffs to come. Too bad
Not a big deal. We just need to expand off label use of products. Great idea at NSM from an Avastin counterpart underwriting off site Journal Club for Pancreatic Cancer. Manager approved and Genentech Internal cut the check.
Not a big deal. We just need to expand off label use of products. Great idea at NSM from an Avastin counterpart underwriting off site Journal Club for Pancreatic Cancer. Manager approved and Genentech Internal cut the check.
I thought Genentech Reps were "Biotech" reps and docs were opening the door and just letting them walk in. Maybe their reps are poorly trained and no credibility. Looks a little desperate for this type of activity to be happening.
Sounds like a jealous Lilly rep. We like our high end vehicles (Jags, Mercedes, Lexus, BMW) and having a complinace team that works well with commercial. Compliance understands how important sales are at all costs with our wonder drugs. Doctors are opening doors for us all the time.
Its George Bush's fault...........No, it's the roach people. We will be so glad when you're gone.